查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830950

血管通路設備市場

Vascular Access Devices Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格
簡介目錄

2024 年血管通路設備市場價值為 65.1 億美元，預計到 2031 年將達到 111 億美元，2025 年至 2031 年的複合年成長率預計為 7.9%。

市場洞察與分析師觀點：血管通路裝置可經由各種解剖部位進入上腔靜脈或下腔靜脈，包括頸內靜脈、鎖骨下靜脈、頸外靜脈和股靜脈。血管通路裝置市場的擴張主要受慢性病發病率上升和化療需求成長的驅動。此外，企業為維持市場競爭力而採取的策略行動也促進了這一成長。預計在預測期內，人工智慧機器人靜脈通路裝置的採用率將顯著上升，這將為血管通路裝置市場帶來新的趨勢。

成長因素與挑戰：化療是一種主要或輔助治療方法，旨在透過強效藥物治療來減少或根除腫瘤。因此，癌症病例的增加增加了對化療的需求。根據國際癌症研究機構 (IARC) 的數據，2020 年全球報告新增癌症病例 1,930 萬例，導致約 1,000 萬人死亡。南非國家癌症登記處 (NCR) 報告稱，2020 年新增癌症診斷病例約 11 萬例，癌症相關死亡病例超過 56,000 例。此外，預計未來幾十年疾病負擔將加劇，預計到 2030 年和 2040 年新增癌症病例將分別達到 138,000 例和 175,000 例，而癌症相關死亡人數預計將分別上升至 73,000 例和 94,000 例。因此，癌症發生率的上升推動了血管通路設備市場的成長。

戰略洞察

報告細分和範圍：透過檢查以下細分市場對血管通路設備市場進行分析：產品類型、應用、插入途徑、最終用戶和地理位置。市場依產品類型分為短周邊靜脈導管、中線導管、PICC（周邊插入中心靜脈導管）、中心靜脈導管、植入式連接埠和配件。中心靜脈導管部分進一步分為CICC（中心插入中心靜脈導管）、FICC（股動脈插入中心靜脈導管）等。在應用方面，血管通路設備市場細分為藥物管理、液體和營養管理、血液製品輸血等。插入途徑將市場分為皮下和靜脈內。依最終用戶細分，市場分為醫院和診所、門診手術中心等。血管通路設備市場報告的地理範圍包括北美（美國、加拿大和墨西哥）、歐洲（西班牙、英國、德國、法國、義大利和歐洲其他地區）、亞太地區（韓國、中國、日本、印度、澳洲和亞太其他地區）、中東和非洲（南非、沙烏地阿拉伯、阿拉伯聯合大公國和中東和非洲其他地區）以及南美洲和中美洲（巴西、阿根廷和南美洲和中美洲其他地區）。

細分分析：血管通路設備市場按產品類型細分為短周邊靜脈導管、中線導管、PICC（周邊插入中心靜脈導管）、中心靜脈導管、植入式輸液港和配件。中心靜脈導管細分市場進一步細分為CICC（中心靜脈插入中心靜脈導管）、FICC（股靜脈插入中心靜脈導管）和其他。 2022年，短周邊靜脈導管細分市場佔據血管通路設備市場的最大佔有率，預計在2022年至2030年期間的複合年成長率最高。

就應用而言，血管通路設備市場分為藥物管理、液體和營養管理、血液製品輸注及其他。藥物管理領域在2022年佔據最大佔有率，預計在2022年至2030年期間將呈現最高的複合年成長率。

就插入途徑而言，血管通路器械市場分為皮下和靜脈。靜脈通路在2022年佔據了更大的市場佔有率，預計在2022年至2030年期間將實現更高的複合年成長率。

按最終用戶分類，市場分為醫院和診所、門診手術中心和其他。預計2022年至2030年期間，醫院和診所的血管通路設備市場將持續成長。

區域分析：北美是全球血管通路器械市場成長的主要貢獻者。預計亞太地區將在2022年至2030年期間實現最高的複合年成長率。 2022年，北美佔據了全球市場的最大佔有率，這得益於慢性病患病率的上升、老齡人口的成長、參與產品開發的關鍵市場參與者的存在以及技術的進步。在北美，美國在2022年佔據了最大的市場。

血管通路設備市場報告範圍

產業發展與未來機會：血管通路設備市場的預測是基於各種二手和一手研究成果，包括主要公司出版物、協會資料和資料庫。根據主要市場參與者的新聞稿，概述了以下幾種策略：

2023年11月，BD（碧迪公司）推出了與整合導管相容的新型無針採血技術，助力公司實現「一次扎針住院」的願景。 PIVO Pro無針採血裝置的設計已改進，可相容於整合式和長型周邊靜脈導管，包括配備NearPort靜脈通路的新型Nexiva封閉式靜脈導管系統。 2023年5月，泰利福公司推出了兩款新設備——Arrow VPS Rhythm DLX設備和NaviCurve Stylet，旨在改善PICC置管流程並最大限度地減少併發症。 VPS Rhythm DLX設備利用患者的心電活動提供即時導管尖端位置資訊。 NaviCurve Stylet採用符合人體解剖學的曲線和靈活的尖端設計，可根據患者解剖結構進行自我定位，以便PICC更好地推進至上腔靜脈(SVC)並成功置管。

競爭格局和主要公司：Teleflex Inc、BD、B. Braun SE、Terumo Medical Corporation、Medtronic、Fresenius Kabi、Baxter、Vygon SAS、Kimal 和 Access Vascular Inc 是血管通路設備市場報告中重點介紹的關鍵參與者。此外，報告還考察和分析了其他幾家公司，以提供對市場及其生態系統的全面了解。這些公司專注於地理擴張和新產品發布，以滿足全球消費者日益成長的需求，並增強其在專業產品組合中的供應。他們的全球影響力使他們能夠滿足龐大的客戶群，從而促進市場成長。

目錄

第1章：簡介

第 2 章：執行摘要

  • 關鍵見解
  • 市場吸引力分析

第3章：研究方法

第4章：血管通路設備市場格局

  • 概述
  • PEST分析
  • 生態系分析
    • 價值鏈中的供應商列表

第5章：血管通路設備市場－關鍵市場動態

  • 關鍵市場促進因素
  • 主要市場限制因素
  • 關鍵市場機會
  • 未來趨勢
  • 促進因素和限制因素的影響分析

第6章：血管通路設備市場－全球市場分析

  • 血管通路設備 - 全球市場概覽
  • 血管通路設備－全球市場及2030年預測

第7章：血管通路設備市場-收入分析-依類型，2020-2030

  • 概述
  • 短周邊靜脈導管
  • 中線導管
  • 中國人保中心
  • 中心導管
  • 植入式輸液港
  • 配件

第 8 章：血管通路設備市場 - 收入分析 - 按應用，2020-2030 年

  • 概述
  • 藥品管理局
  • 輸血
  • 液體和營養管理
  • 其他

第 9 章：血管通路設備市場 - 收入分析 - 按最終用戶，2020-2030 年

  • 概述
  • 醫院和診所
  • 門診手術中心
  • 其他

第 10 章：血管通路設備市場 - 收入分析，2020-2030 年 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 歐洲其他地區
  • 亞太
    • 澳洲
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 11 章：產業格局

  • 併購
  • 協議、合作、合資企業
  • 新產品發布
  • 擴張和其他策略發展

第 12 章：競爭格局

  • 關鍵參與者的熱圖分析
  • 公司定位與集中度

第 13 章：血管通路設備市場 - 主要公司簡介

  • B Braun Melsungen AG
  • NIPRO Medical Corporation
  • Smiths Medical
  • Becton, Dickinson, and Company
  • Terumo Corporation
  • Teleflex Incorporated
  • Edwards Lifesciences Corporation
  • AngioDynamics
  • Ameco Medical
  • Vygon Ltd

第 14 章：附錄

簡介目錄
Product Code: TIPHE100000983

The vascular access devices market was valued at US$ 6.51 billion in 2024 and is anticipated to reach US$ 11.10 billion by 2031, with a projected CAGR of 7.9% from 2025 to 2031.

Market Insights and Analyst Perspective:Vascular access devices are utilized through various anatomical sites to access the superior or inferior vena cava, including the internal jugular vein, subclavian vein, external jugular vein, and femoral vein. The expansion of the vascular access devices market is primarily driven by the increasing incidence of chronic diseases and the growing demand for chemotherapy treatments. Furthermore, strategic actions by companies to maintain competitiveness in the market contribute to this growth. A notable rise in the adoption of AI-enabled robotic venous access devices is expected to introduce new trends in the vascular access device market throughout the forecast period.

Growth Factors and Challenges:Chemotherapy serves as a primary or adjunctive treatment aimed at reducing or eradicating tumors through potent drug administration. Consequently, the rising number of cancer cases boosts the demand for chemotherapy procedures. According to the International Agency for Research on Cancer (IARC), there were 19.3 million new cancer cases reported worldwide in 2020, resulting in approximately 10 million deaths. The National Cancer Registry (NCR) in South Africa reported around 110,000 new cancer diagnoses and over 56,000 cancer-related fatalities in 2020. Additionally, the disease burden is expected to escalate in the coming decades, with projections of new cancer cases reaching 138,000 and 175,000 by 2030 and 2040, respectively, while cancer-related deaths are anticipated to rise to 73,000 and 94,000 in those years. Thus, the increasing prevalence of cancer propels the growth of the vascular access devices market.

Strategic Insights

Report Segmentation and Scope:The analysis of the vascular access devices market has been conducted by examining the following segments: product type, application, route of insertion, end user, and geography. The market is categorized by product type into short peripheral intravenous catheters, midline catheters, PICC (peripherally inserted central catheters), central catheters, implantable ports, and accessories. The central catheter segment is further divided into CICC (centrally inserted central catheter), FICC (femorally inserted central catheter), and others. In terms of application, the vascular access devices market is segmented into drug administration, fluid and nutrition administration, blood product transfusion, and others. The route of insertion divides the market into subcutaneous and intravenous. By end users, the market is segmented into hospitals and clinics, ambulatory surgical centers, and others. The geographical scope of the vascular access devices market report includes North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, Japan, India, Australia, and the Rest of Asia Pacific), the Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Segmental Analysis:The vascular access devices market is segmented by product type into short peripheral intravenous catheters, midline catheters, PICC (peripherally inserted central catheters), central catheters, implantable ports, and accessories. The central catheter segment is further divided into CICC (centrally inserted central catheter), FICC (femorally inserted central catheter), and others. In 2022, the short peripheral intravenous catheter segment held the largest share of the vascular access devices market and is projected to exhibit the highest CAGR from 2022 to 2030.

In terms of application, the vascular access devices market is divided into drug administration, fluid and nutrition administration, blood product transfusion, and others. The drug administration segment accounted for the largest share in 2022 and is expected to show the highest CAGR during the period from 2022 to 2030.

Regarding the route of insertion, the vascular access devices market is split into subcutaneous and intravenous. The intravenous segment captured a larger market share in 2022 and is predicted to achieve a higher CAGR from 2022 to 2030.

By end user, the market is categorized into hospitals and clinics, ambulatory surgical centers, and others. The vascular access devices market for hospitals and clinics is anticipated to grow during the period from 2022 to 2030.

Regional Analysis:North America is the leading contributor to the global growth of the vascular access devices market. The Asia Pacific region is expected to experience the highest CAGR in the market from 2022 to 2030. North America held the largest share of the global market in 2022, driven by the increasing prevalence of chronic conditions, a growing elderly population, the presence of key market players engaged in product development, and advancements in technology. In North America, the US accounted for the largest market share in 2022.

Vascular Access Devices Market Report Scope

Industry Developments and Future Opportunities:The forecast for the vascular access devices market is based on various secondary and primary research findings, including key company publications, association data, and databases. According to press releases from major market players, several strategies are outlined below:

In November 2023, BD (Becton, Dickinson, and Company) introduced new needle-free blood draw technology compatible with integrated catheters, supporting the company's vision of a "One-Stick Hospital Stay." The PIVO Pro Needle-free Blood Collection Device features design enhancements for compatibility with integrated and long peripheral IV catheters, including the new Nexiva Closed IV Catheter System with NearPort IV Access.In May 2023, Teleflex Inc. launched two new devices-Arrow VPS Rhythm DLX Device and NaviCurve Stylet-aimed at improving PICC insertion procedures and minimizing complications. The VPS Rhythm DLX Device offers real-time catheter tip location information by utilizing the patient's cardiac electrical activity. The NaviCurve Stylet is designed with an anatomical curve and flexible tip to self-orient to patient anatomy for better PICC advancement into the superior vena cava (SVC) for successful insertion.

Competitive Landscape and Key Companies:Teleflex Inc, BD, B. Braun SE, Terumo Medical Corporation, Medtronic, Fresenius Kabi, Baxter, Vygon SAS, Kimal, and Access Vascular Inc are among the key players highlighted in the vascular access devices market report. Additionally, several other companies have been examined and analyzed to provide a comprehensive view of the market and its ecosystem. These companies are focused on geographic expansion and new product launches to meet the increasing demand from consumers globally and to enhance their product offerings in specialty portfolios. Their global presence enables them to cater to a vast customer base, thereby facilitating market growth.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Vascular Access Devices Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Vascular Access Devices Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Vascular Access Devices Market - Global Market Analysis

  • 6.1 Vascular Access Devices - Global Market Overview
  • 6.2 Vascular Access Devices - Global Market and Forecast to 2030

7. Vascular Access Devices Market - Revenue Analysis (USD Million) - By Type, 2020-2030

  • 7.1 Overview
  • 7.2 Short Peripheral Intravenous Catheters
  • 7.3 Midline Catheters
  • 7.4 PICC
  • 7.5 Central Catheters
    • 7.5.1 Centrally Inserted central Catheters
    • 7.5.2 Femoral Inserted Central Catheters
  • 7.6 Implantable Ports
  • 7.7 Accessories

8. Vascular Access Devices Market - Revenue Analysis (USD Million) - By Application, 2020-2030

  • 8.1 Overview
  • 8.2 Drug Administration
  • 8.3 Blood Transfusion
  • 8.4 Fluid and Nutrition Administration
  • 8.5 Others

9. Vascular Access Devices Market - Revenue Analysis (USD Million) - By End User, 2020-2030

  • 9.1 Overview
  • 9.2 Hospitals and Clinics
  • 9.3 Ambulatory Surgical Centers
  • 9.4 Others

10. Vascular Access Devices Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

  • 10.1 North America
    • 10.1.1 North America Vascular Access Devices Market Overview
    • 10.1.2 North America Vascular Access Devices Market Revenue and Forecasts to 2030
    • 10.1.3 North America Vascular Access Devices Market Revenue and Forecasts and Analysis - By Type
    • 10.1.4 North America Vascular Access Devices Market Revenue and Forecasts and Analysis - By Application
    • 10.1.5 North America Vascular Access Devices Market Revenue and Forecasts and Analysis - By End User
    • 10.1.6 North America Vascular Access Devices Market Revenue and Forecasts and Analysis - By Countries
      • 10.1.6.1 United States Vascular Access Devices Market
        • 10.1.6.1.1 United States Vascular Access Devices Market, by Type
        • 10.1.6.1.2 United States Vascular Access Devices Market, by Application
        • 10.1.6.1.3 United States Vascular Access Devices Market, by End User
      • 10.1.6.2 Canada Vascular Access Devices Market
        • 10.1.6.2.1 Canada Vascular Access Devices Market, by Type
        • 10.1.6.2.2 Canada Vascular Access Devices Market, by Application
        • 10.1.6.2.3 Canada Vascular Access Devices Market, by End User
      • 10.1.6.3 Mexico Vascular Access Devices Market
        • 10.1.6.3.1 Mexico Vascular Access Devices Market, by Type
        • 10.1.6.3.2 Mexico Vascular Access Devices Market, by Application
        • 10.1.6.3.3 Mexico Vascular Access Devices Market, by End User
  • 10.2 Europe
    • 10.2.1 Germany
    • 10.2.2 France
    • 10.2.3 Italy
    • 10.2.4 Spain
    • 10.2.5 United Kingdom
    • 10.2.6 Rest of Europe
  • 10.3 Asia-Pacific
    • 10.3.1 Australia
    • 10.3.2 China
    • 10.3.3 India
    • 10.3.4 Japan
    • 10.3.5 South Korea
    • 10.3.6 Rest of Asia-Pacific
  • 10.4 Middle East and Africa
    • 10.4.1 South Africa
    • 10.4.2 Saudi Arabia
    • 10.4.3 U.A.E
    • 10.4.4 Rest of Middle East and Africa
  • 10.5 South and Central America
    • 10.5.1 Brazil
    • 10.5.2 Argentina
    • 10.5.3 Rest of South and Central America

11. Industry Landscape

  • 11.1 Mergers and Acquisitions
  • 11.2 Agreements, Collaborations, Joint Ventures
  • 11.3 New Product Launches
  • 11.4 Expansions and Other Strategic Developments

12. Competitive Landscape

  • 12.1 Heat Map Analysis by Key Players
  • 12.2 Company Positioning and Concentration

13. Vascular Access Devices Market - Key Company Profiles

  • 13.1 B Braun Melsungen AG
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 NIPRO Medical Corporation
  • 13.3 Smiths Medical
  • 13.4 Becton, Dickinson, and Company
  • 13.5 Terumo Corporation
  • 13.6 Teleflex Incorporated
  • 13.7 Edwards Lifesciences Corporation
  • 13.8 AngioDynamics
  • 13.9 Ameco Medical
  • 13.10 Vygon Ltd

14. Appendix

  • 14.1 Glossary
  • 14.2 About The Insight Partners
  • 14.3 Market Intelligence Cloud